Lutz W - Search Results

1

High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.

Westermann F, Henrich KO, Wei JS, Lutz W, Fischer M, König R, Wiedemeyer R, Ehemann V, Brors B, Ernestus K, Leuschner I, Benner A, Khan J, Schwab M. Westermann F, et al. Among authors: lutz w. Clin Cancer Res. 2007 Aug 15;13(16):4695-703. doi: 10.1158/1078-0432.CCR-06-2818. Epub 2007 Jul 25. Clin Cancer Res. 2007. PMID: 17652624

2

Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma.

Eckerle I, Muth D, Batzler J, Henrich KO, Lutz W, Fischer M, Witt O, Schwab M, Westermann F. Eckerle I, et al. Among authors: lutz w. Cancer Lett. 2009 Nov 18;285(1):99-107. doi: 10.1016/j.canlet.2009.05.007. Epub 2009 Jun 3. Cancer Lett. 2009. PMID: 19497660

3

In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.

Lutz W, Schwab M. Lutz W, et al. Oncogene. 1997 Jul 17;15(3):303-15. doi: 10.1038/sj.onc.1201195. Oncogene. 1997. PMID: 9233765

4

MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells.

Lutz W, Fulda S, Jeremias I, Debatin KM, Schwab M. Lutz W, et al. Oncogene. 1998 Jul 23;17(3):339-46. doi: 10.1038/sj.onc.1200201. Oncogene. 1998. PMID: 9690515

5

MycN sensitizes neuroblastoma cells for drug-triggered apoptosis.

Fulda S, Lutz W, Schwab M, Debatin KM. Fulda S, et al. Among authors: lutz w. Med Pediatr Oncol. 2000 Dec;35(6):582-4. doi: 10.1002/1096-911x(20001201)35:6<582::aid-mpo19>3.0.co;2-2. Med Pediatr Oncol. 2000. PMID: 11107122

6

Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells.

Lutz W, Stöhr M, Schürmann J, Wenzel A, Löhr A, Schwab M. Lutz W, et al. Oncogene. 1996 Aug 15;13(4):803-12. Oncogene. 1996. PMID: 8761302

7

MycN sensitizes neuroblastoma cells for drug-induced apoptosis.

Fulda S, Lutz W, Schwab M, Debatin KM. Fulda S, et al. Among authors: lutz w. Oncogene. 1999 Feb 18;18(7):1479-86. doi: 10.1038/sj.onc.1202435. Oncogene. 1999. PMID: 10050884

8

Down-regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells.

Fotsis T, Breit S, Lutz W, Rössler J, Hatzi E, Schwab M, Schweigerer L. Fotsis T, et al. Among authors: lutz w. Eur J Biochem. 1999 Aug;263(3):757-64. doi: 10.1046/j.1432-1327.1999.00575.x. Eur J Biochem. 1999. PMID: 10469139 Free article.

9

E2F proteins regulate MYCN expression in neuroblastomas.

Strieder V, Lutz W. Strieder V, et al. Among authors: lutz w. J Biol Chem. 2003 Jan 31;278(5):2983-9. doi: 10.1074/jbc.M207596200. Epub 2002 Nov 15. J Biol Chem. 2003. PMID: 12438307 Free article.

10

E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas.

Kramps C, Strieder V, Sapetschnig A, Suske G, Lutz W. Kramps C, et al. Among authors: lutz w. J Biol Chem. 2004 Feb 13;279(7):5110-7. doi: 10.1074/jbc.M304758200. Epub 2003 Nov 26. J Biol Chem. 2004. PMID: 14645238 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

926 results

Search Page

Filters